Topic search: PEDIATRICS

Search the Journal's archive for all articles tagged as being related to your selected topic. Click here to return to the list of all topics.

Refine your search by entering keywords here:

Pediatrics Articles

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2025 Pg. 279-290	Stability Study of Pediatric Oral Suspensions Formulated with PCCA SuspendIt Vehicle Used for the Treatment of Cardiovascular Disease Author(s): Davis Courtaney, Ip Kendice, Banov Daniel, Zdoryk Oleksandr
Jul/Aug 2024 Pg. 268-269	Prescription: Pediatric/Geriatric Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 282-285	Pediatric Compounding: Coloring Outside the Lines Author(s): Preckshot John
Jul/Aug 2024 Pg. 304-305	Calculations: Pediatric Dosing Consideration Author(s): Stockton Shelly J
Jul/Aug 2024 Pg. 309	Ivermectin 0.8% Creme Rinse Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 312	Natural Head Lice Repellant Spray Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 446-448	Compounded "Monster Spray" for Nighttime Terrors: A Case Report Author(s): Riepl Mike
Nov/Dec 2023 Pg. 488	Calculations Author(s): Stockton Shelly J
Jan/Feb 2023 Pg. 72-77	Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base Author(s): Spennacchio Antonio, Lopedota Angela, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Jul/Aug 2022 Pg. 293-296	Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases Author(s): Harrington Amy, Williams LaVonn
May/Jun 2022 Pg. 233	Azstarys in Ora-Blend Single Dose Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 56	Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 506	Quetiapine Fumarate 10 mg/mL in Ora-Blend Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 509	Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 318	Calculations Author(s): Stockton Shelly J
Jul/Aug 2021 Pg. 321	Atomoxetine 4-mg/mL Oral Solution/Suspension Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 258-262	Study on the Optimal Conditions for Long-term Storage of Melatonin Powder as an In-hospital Preparation Author(s): Odanaka Keita, Kojima Hiroki, Nakagawa Naoto
Mar/Apr 2021 Pg. 142	Amlodipine 1-mg/mL in Oral Mix Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 144	Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 40	Calculations Author(s): Stockton Shelly J
Sep/Oct 2020 Pg. 408-412	Always the Right Dose? Content Uniformity in Over 100 Different Formulations Tested Author(s): Dijkers Eli, Polonini Hudson, de Oliveira Ferreira Anderson
Sep/Oct 2019 Pg. 411	Sorafenib Capsules for Pediatric Use Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 324-331	Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients Author(s): de Lafuente Yanina, García Mónica Cristina, Jiminez-Kairuz Alvaro
May/Jun 2019 Pg. 235	Methotrexate 2-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 35-44	Basics of Compounding: Standardization of Compounded Medications Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 444	PreScription: Standardized Concentrations: Pro or Con? Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 358-366	Current Trends and Emerging Priorities in Compounded Preparations for Children Author(s): Parrish Richard H II
Sep/Oct 2017 Pg. 426-429	Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes Author(s): Kirkham Kylian, Munson Jessica M, McCluskey Susan V, Graner Kevin K
Jul/Aug 2017 Pg. 282-289	Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas Author(s): Choo Winnie
Mar/Apr 2017 Pg. 171-175	Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules Author(s): Dijkers Eli, Nanhekhan Valerie, Thorissen Astrid, Polonini Hudson
Jul/Aug 2016 Pg. 277-280	Case Report: Pediatric Scar Management After Open-heart Surgery Author(s): Phan Ha, Harger Beau, Estrada Nick
May/Jun 2016 Pg. 247-249	Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children Author(s): Nahata Milap C
May/Jun 2016 Pg. 257-261	Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children Author(s): Pramann Lance A, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
Jan/Feb 2016 Pg. 6-10	Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis Author(s): Choo Winnie
May/Jun 2015 Pg. 205-211	Practicing Your Compounding Skills Outsides of Your Pharmacy's Walls Author(s): Gonzalez Mark
Mar/Apr 2015 Pg. 146	L-Cysteine Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 427-431	Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition Author(s): Bourget Philippe, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard
Jan/Feb 2014 Pg. 6-12	The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Author(s): Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Nov/Dec 2013 Pg. 446-450	Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 2 Author(s): Horace Alexis E, Akbarian-Tefagh Jessica
Sep/Oct 2013 Pg. 364-368	Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms Author(s): McElhiney Linda F
Sep/Oct 2013 Pg. 388-391	Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 1 Author(s): Horace Alexis E, Akbarian-Tefagh Jessica
Sep/Oct 2013 Pg. 419	Indomethacin 1-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 432-435	Pattern of Extemporaneous Prescriptions and Preparations in a Tertiary Health Institution: A Five-year Assessment Author(s): Aghahowa S E, Egharevba J O, Erhagbe B E, Okoh F
Jan/Feb 2013 Pg. 6-8	Pediatric Health Care: An Introduction Author(s): Williams LaVonn A
Jul/Aug 2012 Pg. 270-274	A Concise Discussion of Headache Types, Part 3: Migraine Author(s): Williams LaVonn A, Allen Loyd V Jr
Nov/Dec 2011 Pg. 446-448	A Retrospective Observational Case Series Analysis of the Usage of Hydroxyprogesterone Caproate for the Prevention of Preterm Labor in Alabama Patients Author(s): Nolan Sara M, Burgess Christopher A
Nov/Dec 2011 Pg. 458-463	Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Author(s): Zur Eyal
Nov/Dec 2011 Pg. 464-469	Diaper Rash Relief: Common Sense Remedies and Treatments Author(s): Wiliams Kacee D, Williams LaVonn
Sep/Oct 2011 Pg. 358-366	Infantile Hemangiomas, Part 1: Treatment with Oral Propranolol Hydrochloride Author(s): Zur Eyal
Sep/Oct 2011 Pg. 386-387	Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient Author(s): McElhiney Linda F
Jul/Aug 2011 Pg. 316-319	Folinic Acid, L-DOPA, and 5-hydroxytryptophan in Tetrahydrobiopterin Deficiency: Treatment Plan for a Pediatric Patient Author(s): Bramwell Bethany
May/Jun 2011 Pg. 194-199	Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient Author(s): McElhiney Linda F
May/Jun 2011 Pg. 200-203	Extemporaneous Preparation of Sertraline Cream for Transdermal Administration Author(s): Wynn Tom, Goetsch Daniel
Mar/Apr 2011 Pg. 124-128	Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Author(s): Corsini Lindsay, Williams LaVonn A
Mar/Apr 2011 Pg. 156	Acetylcysteine 1% or 10% Oral Solution Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 518	Glutathione 25% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 270-274	Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together Author(s): McElhiney Linda F
Jan/Feb 2010 Pg. 21-25	Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet Author(s): McElhiney Linda F, Cheng Angela, Meshberger Laura, Imai Lara
Jan/Feb 2010 Pg. 40-45	Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis Author(s): Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R
Jan/Feb 2010 Pg. 6-8	When Traditional Medicine Fails Author(s): Bash Robert
Jan/Feb 2010 Pg. 58-59	Calculations Author(s): Stockton Shelly J
Sep/Oct 2009 Pg. 431	Emanuel Butt Paste Author(s): Allen Loyd V Jr
Jul/Aug 2009 Pg. 314-317	Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding Author(s): Glaser Rebecca L, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel
Jul/Aug 2009 Pg. 296-299	Compounding Naltrexone for the Treatment of Autism Author(s): Wynn Tom, Brunetti Sarah
May/Jun 2009 Pg. 220-221	Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report Author(s): Muller George
Jan/Feb 2009 Pg. 6-12	Compounding for Pediatric Patients: Case Reports and Formulations Author(s): Mixon William, Angelle Patricea, Yoch Douglas
Jan/Feb 2009 Pg. 14-18	Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports Author(s): Haase Mark R, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George
Jan/Feb 2009 Pg. 63	Calculations Author(s): Stockton Shelly J
Jan/Feb 2009 Pg. 64	Acetaminophen, Pseudoephedrine Hydrochloride, and Chlorpheniramine Maleate Powder Packets Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 65	Amphotericin B, Chloramphenicol Palmitate, Hydrocortisone, and Sulfanilamide Otic Powder Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 68	Diaper Rash Cream with Miconazole Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 69	Diphenhydramine Hydrochloride 25-mg Gelatin Troches Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 365-367	Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada Author(s): Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
May/Jun 2008 Pg. 261	Benzyl Benzoate Lotion Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 269	Valsartan 4-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 73	Trimethoprim 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 220-225	Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
May/Jun 2007 Pg. 249	Methylphenidate 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2007 Pg. 116-120	Challenges of Compounding for Patients on the Ketogenic Diet Author(s): McElhiney Linda F
Mar/Apr 2007 Pg. 161	Ranitidine Hydrochloride 15-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 5-8	Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1 Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
Jan/Feb 2007 Pg. 10-15	Principles of Pediatric Palliative Care and Pain Control Author(s): Peralta Alexander Jr
Jan/Feb 2007 Pg. 17-19	Pediatric Oral Formulations: A Continual Challenge Author(s): Hurtado Josephine, Moffett Brady S
Jan/Feb 2007 Pg. 20-24	Sevelamer Suspension in Children with End-Stage Renal Disease Author(s): McElhiney Linda F
Jan/Feb 2007 Pg. 26-27	Case Report: Cocktail Dosing in a Premature Infant with a History of Cholestasis Author(s): Fields Shannon W
Jan/Feb 2007 Pg. 27	Case Report: Treatment of Labial Adhesions in a Child Author(s): Fields Shannon W
Jan/Feb 2007 Pg. 68	Calculations Author(s): Stockton Shelly J
Jan/Feb 2007 Pg. 69	Caffeine Citrate 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 70	Carbidopa 1.25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 71	Clonidine Hydrochloride 0.1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 75	Methyldopa 25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 76	Metolazone 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 77	Prednisone 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 78	Prednisolone Sodium Phosphate 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2006 Pg. 388	Nitrazepam 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2006 Pg. 390	Oral Rehydration Salts (World Health Organization/United Nations Children's Fund) Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 299	Adderall 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 302	Lisinopril 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 303	Nifedipine 4-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 304	Propranolol Hydrochloride 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2006 Pg. 67	Propylthiouracil 5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 410	Prescription: Pediatric Formulation Initiatives Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 413-420	Unlocking Autism: Is Compounding the Key? Author(s): Vail Jane
Nov/Dec 2005 Pg. 423-431	Compounding for a Pediatric Hospital Author(s): McElhiney Linda F
Nov/Dec 2005 Pg. 433-434 View Sample	Wiping Out Diaper Rash Author(s): Fields Shannon W
Nov/Dec 2005 Pg. 437-442	Pediatric Oral Liquid Preparations Author(s): Fonseca Simonne C, Ferreira Anderson de O
Nov/Dec 2005 Pg. 456-461	Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions Author(s): Fonseca Simonne C
Nov/Dec 2005 Pg. 487-488	PostScription: Compounding Pharmacies and the Successful Treatment of Autism Author(s): Neurander James A
Jan/Feb 2005 Pg. 57	Calculations Author(s): Prince Shelly J
Jan/Feb 2005 Pg. 82-86	Stability of an Extemporaneously Compounded Propylthiouracil Suspension Author(s): Alexander Kenneth S, Mitra Pallabi
Nov/Dec 2004 Pg. 458-460	A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid Author(s): McElhiney Linda F
Sep/Oct 2004 Pg. 329-335	Domperidone in Lactation: Use as a Galactagogue Author(s): Albright Lisa M
Sep/Oct 2004 Pg. 345-352	Head to Toe Solutions: A Quick Review of Current Therapies Author(s): Paoletti James E
Jul/Aug 2004 Pg. 244-249	Book and Literature Reviews Author(s): Reed-Kane Dana, Foy Elizabeth, MacCara Mary E
May/Jun 2004 Pg. 184	Gag Tablet Lollipops Author(s): Hinkle Amanda R, Newton Gail D
May/Jun 2004 Pg. 214	Amiodarone HCl 5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 215	Atenolol 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 218	Glycopyrrolate 0.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2004 Pg. 134	Flucytosine 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2004 Pg. 135	Griseofulvin 25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2004 Pg. 140	Stomatitis Mouthwash Author(s): Allen Loyd V Jr
Mar/Apr 2004 Pg. 141	Tacrolimus 0.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2004 Pg. 142	Tiagabine 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2003 Pg. 474	Sulfasalazine 250-mg/5-mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2003 Pg. 485-489	Stability of Two Concentrations of Tiagabine in an Extemporaneously Compounded Suspension Author(s): Haase Mark R, Khan Mansoor A, Bonilla Jeremiah
Sep/Oct 2003 Pg. 381	Thioridazine HCl 100-mg/mL Concentrated Solution Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 376	Isoniazid 10-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 382	Ursodiol 150-mg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 389-393	Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride Author(s): Alexander Kenneth S, Thyangarajapuram N
Sep/Oct 2003 Pg. 394-398	Educating the Caregiver and Community Pharmacist To Facilitate Provision of Consistent Compounded Medications from the Inpatient to Ambulatory Settings Author(s): McElhiney Linda F
Jul/Aug 2003 Pg. 313-319	Stability of Hydralazine HCl in Both Flavored and Nonflavored Extemporaneous Preparations Author(s): Okeke Claudia C, Medwick Thomas, Nairn Graham, Shaila Khuspe, Grady Lee T
Nov/Dec 2002 Pg. 419-421	Pediatric Dermatitis Author(s): Remmert Renee
Nov/Dec 2002 Pg. 423	Excerpts from and Reviews of Current Published Literature: Pediatric Medications Author(s): Foy Elizabeth, MacCara Mary E
Nov/Dec 2002 Pg. 424-425	Book Reviews: Compounding for Pediatric Patients Author(s): Ashworth Lisa D, Reed-Kane Dana
Nov/Dec 2002 Pg. 449	Caffeine and Sodium Benzoate 250-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2002 Pg. 451	Dimenhydrinate 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2002 Pg. 367	Erythromycin 400-mg/mL and Rifampin 50-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2001 Pg. 436-437	Topical Secretin for the Treatment of Autism Author(s): King Erin, Toney Steve
Jul/Aug 2001 Pg. 294-297	Basics of Compounding: Suspensions Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 296	Suspension Structured Vehicle, USP Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 296	Sugar-Free Suspension Structured Vehicle, USP Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 297	Spironolactone Oral Suspension 2-mg/mL Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 297	Progesterone Oral Suspension 40-mg/mL Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 297	Xanthan Gum Oral Suspension Vehicle 0.3% Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 306	Pediatric Preoperative Cocktail Injection Author(s): Allen Loyd V Jr
May/Jun 2001 Pg. 198-201	The Basics of Compounding Emulsions, Part 2 Author(s): Allen Loyd V Jr
Mar/Apr 2001 Pg. 120-123	The Basics of Compounding Emulsions, Part 1 Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 6-8	Pediatric Compounding: Coloring Outside the Lines Author(s): Preckshot John
Jan/Feb 2001 Pg. 9-12	Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Author(s): Schotik Debora
Jan/Feb 2001 Pg. 13-16	Flavoring: Compounding a Treat Author(s): Kloesel Lawson G
Jan/Feb 2001 Pg. 18-19	Autism in Children Author(s): Cave Stephanie
Jan/Feb 2001 Pg. 21-22	Methylphenidate in the Treatment of Attention Deficit Disorders Author(s): Tenreiro Kim
Jan/Feb 2001 Pg. 23-25	A Pediatric Miscellany: Excerpts from and Reviews of Current Published Literature Author(s): Foy Elizabeth, MacCara Mary E
Jan/Feb 2001 Pg. 30-31	Compounding in History: Pediatric Considerations Author(s): Worthen Dennis B
Jan/Feb 2001 Pg. 38	Electrolyte and Rehydration Powder for Solution-Example of Powder Formulations Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 42	Cholestyramine 6.5% Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 43	Ivermectin 0.8% Creme Rinse Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 44	Lidocaine HCl 4%-Epinephrine HCl 0.05%-Tetracaine HCl 0.5% Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 45	Lorazepam 1-mg Chewable Gummy Gels Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 46	Metronidazole Benzoate 400-mg/5-mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 48	Natural Head Lice Repellant Spray Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 49	Niacinamide 4% Acne Gel Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 51	Promethazine HCl 50-mg/mL in PLO Gel Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 289-293	Basics of Compounding: Compounding Suppositories: Part I - Theoretical Considerations Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 305	Ondansetron HCl 8-mg/mL in PLO Author(s): Allen Loyd V Jr
May/Jun 2000 Pg. 164-169	Compounding Ear, Nose and Throat Preparations Author(s): Allen Loyd V Jr
May/Jun 2000 Pg. 171-174	Xylitol in the Prevention of Otitis Media Author(s): Glasnapp Andrew
May/Jun 2000 Pg. 175	Sildenafil 0.2% Otic Drops Author(s): Holland Robert T, Quisling Richard
May/Jun 2000 Pg. 208	Amphotericin B 100-mg Troches Author(s): Allen Loyd V Jr
May/Jun 2000 Pg. 214	Nystatin 250,000-Unit and/or Tetracaine HCl 0.025% Popsicles Author(s): Allen Loyd V Jr
Mar/Apr 2000 Pg. 122-125	Basics of Compounding: Compounding Solutions Author(s): Allen Loyd V Jr
Mar/Apr 2000 Pg. 136	Sugar-Free Suspension Structured Vehicle, USP Author(s): Allen Loyd V Jr
Nov/Dec 1999 Pg. 461-465	The Basics of Compounding: Compounding Hard, Soft and Chewable Troches/Lozenges/Drops Author(s): Allen Loyd V Jr
Nov/Dec 1999 Pg. 462	Linguet Base (Soft Lozenge) Author(s): Allen Loyd V Jr
Nov/Dec 1999 Pg. 462	Sorbitol Based Hard Lozenges Author(s): Allen Loyd V Jr
Nov/Dec 1999 Pg. 462	Sucrose Based Hard Lozenges Author(s): Allen Loyd V Jr
Nov/Dec 1999 Pg. 463	Polyethylene Glycol (PEG) Troches (Soft Lozenges) Author(s): Allen Loyd V Jr
Nov/Dec 1999 Pg. 463	Polyethylene Glycol (PEG) Troches with Suspending Agent (Soft Lozenges) Author(s): Allen Loyd V Jr
Nov/Dec 1999 Pg. 464	Chewable Lozenges Author(s): Allen Loyd V Jr
Nov/Dec 1999 Pg. 474	Methotrexate 2.5-mg/5-mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 1999 Pg. 274-276	Extemporaneous Formulations in Pediatric Patients Author(s): Nahata Milap C
Mar/Apr 1999 Pg. 148-155	Analysis of Extemporaneous Alprostadil Formulations Author(s): Sarver Jeffrey G, Peng Ning, Lerdkanchanaporn Supaporn, Oravecz-Wilson Katherine, Alexander Kenneth S, Erhardt Paul W
Jan/Feb 1999 Pg. 10	Oral Ulceration Mouthwash Author(s): Allen Loyd V Jr
Nov/Dec 1998 Pg. 412	Alternatives for the Lactose-Intolerant Patient Author(s): Glasnapp Andrew
Sep/Oct 1998 Pg. 368	Pediatric Central Parenteral Nutrition Solution Author(s): Allen Loyd V Jr
Sep/Oct 1998 Pg. 369	Pediatric Central Parenteral Nutrition Solution with Heparin Author(s): Allen Loyd V Jr
Sep/Oct 1998 Pg. 370	Pediatric Peripheral Parenteral Nutrition Solution Author(s): Allen Loyd V Jr
Jul/Aug 1998 Pg. 268-269	Malathion Topical Lotion: Therapy for Resistant Head Lice Author(s): Glasnapp Andrew, Nguyen Linh
Jul/Aug 1998 Pg. 318-321	Compatibility and Stability of Ranitidine Hydrochloride with Six Cephalosporins During Simulated Y-Site Administration Author(s): Inagaki Kazuhiro, Kambara Motoya, Mizuno Munemichi, Gill Mark A, Nishida Mikio
Mar/Apr 1998 Pg. 159	Tetracaine HCl 1%, Epinephrine HCl 0.025% and Cocaine HCl 4% Topical Solution and Gel Author(s): Allen Loyd V Jr
Mar/Apr 1998 Pg. 160-161	Vehicles for Compounding Oral Liquids: Some Practical Considerations Author(s): Palmer Henry A
Jan/Feb 1998 Pg. 83-88	Ondansetron Suppositories: Extemporaneous Preparation, Drug Release, Stability and Flux through Rabbit Rectal Membrane Author(s): Tenjarla Srini N, Ward Earl S, Fox Janet L
Nov/Dec 1997 Pg. 414	Ketoconazole 20-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 1997 Pg. 321	Baclofen 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 1997 Pg. 322	Captopril 0.75-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 1997 Pg. 323	Diltiazem HCl 12-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 1997 Pg. 278-279	Stability of Bethanechol Chloride Oral Liquid Dosage Forms Author(s): Gupta Vishnu D, Maswoswe J
May/Jun 1997 Pg. 174	Allopurinol 20-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 1997 Pg. 176	Dipyridamole 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 1997 Pg. 179	Labetalol HCl 40-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 1997 Pg. 180	Metoprolol Tartrate 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 1997 Pg. 183	Spironolactone 5-mg/mL with Hydrochlorothiazide 5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 1997 Pg. 184	Spironolactone 25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 1997 Pg. 188	Verapamil HCl 50-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 1997 Pg. 195-199	The Formulation Development and Stability of Spironolactone Suspension Author(s): Alexander Kenneth S, Vangala Shyam Sundar KS, White Donald B, Dollimore David
May/Jun 1997 Pg. 200-205	The Formulation Development and Stability of Metronidazole Suspension Author(s): Alexander Kenneth S, Vangala Shyam Sundar KS, Dollimore David
May/Jun 1997 Pg. 202	Metronidazole 15-mg/mL Suspension Author(s): Gupta Vishnu D, Maswoswe J, Bailey RE
Mar/Apr 1997 Pg. 84-86	Compounding for the Pediatric Patient Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 87-89	Attention Deficit Hyperactivity Disorder Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 90-92	Flavors and Flavoring Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 93-99	Compounded Suppositories and Pharmaceutical Care Author(s): Duncan-Hewitt Wendy, Rains John
Mar/Apr 1997 Pg. 101	Acetazolamide 25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 102	Azathioprine 50-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 103	Flecainide Acetate 20-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 104	Methylcellulose 1% to 5% Solutions Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 105	Methylcellulose Oral-Liquid Vehicles Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 106	Pediatric Chewable Gummy Gel Base Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 106	Pediatric Chocolate Troche Base Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 107	Pediatric Chewable Gummy Gels Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 108	Pediatric Chocolate Troche Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 109	Nystatin Popsicles Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 110	Procainamide HCl 50-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 111	Syrup NF Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 112	Tetracaine 20-mg Lollipops Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 113	Tetracycline Compound Troche Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 114	Xanthan Gum Suspension Vehicle (0.2% to 0.5%) Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 13	Omeprazole (Prilosec) in the Atypical Patient, Administration of Author(s): Kane Dana Lynn
Jan/Feb 1997 Pg. 29	HDDM Hard Troche Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 30	HDDM Soft Troche Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 30	HDDM Sugar Troche Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 31	Metoclophen Nausea Suppositories Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 31	Metoclophen-Modified Nausea Suppositories Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 60-63	Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets Author(s): Alexander Kenneth S, Kothapalli Madhu R, Dollimor David